Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study by Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran

Get full text

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia by Rosas, Ivan O, Bräu, Norbert, Waters, Michael, Go, Ronaldo C, Hunter, Bradley D, Bhagani, Sanjay, Skiest, Daniel, Aziz, Mariam S, Cooper, Nichola, Douglas, Ivor S, Savic, Sinisa, Youngstein, Taryn, Lorenzo Del Sorbo, Antonio Cubillo Gracian, David J. De La Zerda, Ustianowski, Andrew, Bao, Min, Dimonaco, Sophie, Graham, Emily, Matharu, Balpreet, Spotswood, Helen, Tsai, Larry, Malhotra, Atul

Request full text

Recommendations on the use of azole antifungals in hematology-oncology patients by Azanza, J R, Mensa, J, Barberán, J, Vázquez, L, Pérez de Oteyza, J, Kwon, M, Yáñez, L, Aguado, J M, Cubillo Gracian, A, Solano, C, Ruiz Camps, I, Fortún, J, Salavert Lletí, M, Gudiol, C, Olave Rubio, T, García-Vidal, C, Rovira Tarrats, M, Suárez-Lledó Grande, M, González-Sierra, P, Dueñas Gutiérrez, C

Get full text

EP-1474: IMRT and Integrated-boost as neoadjuvant chemoradiation for rectal cancer by Hernando Requejo, O., Lopez Gonzalez, M., Sanchez Saugar, E., Cubillo Gracian, A., Vicente Lopez, E., Montero Luis, A., Ciervide Jurio, R., Garcia Aranda, M., Valero Albarran, J., Gonzalo Ruiz, S., Alonso Gutierrez, R., Rodriguez Pascual, J., Quijano Collazo, Y., Perez Moreno, J., Fernandez Leton, P., Rubio Rodriguez, C.

Get full text

Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study by Harding, James J, Fan, Jia, Oh, Do-Youn, Choi, Hye Jin, Kim, Jin Won, Chang, Heung-Moon, Bao, Lequn, Sun, Hui-Chuan, Macarulla, Teresa, Xie, Feng, Metges, Jean-Phillippe, Ying, Jie'er, Bridgewater, John, Lee, Myung-Ah, Tejani, Mohamedtaki A, Chen, Emerson Y, Kim, Dong Uk, Wasan, Harpreet, Ducreux, Michel, Bao, Yuanyuan, Boyken, Lisa, Ma, Jiafang, Garfin, Phillip, Pant, Shubham, Abou-Alfa, Ghassan, Alfonso, Jorge Adeva, Aglietta, Massimo, Baron, Ari, Beg, Muhammad, Aguirre, Paula Carrasco, Chen, Eric, Cheng, Ying, Gracián, Antonio Cubillo, Dahan, Laetitia, De Braud, Filippo, Fenocchio, Elisabetta, Gbolohon, Olumide, Gillmore, Roopinder, Jary, Marine, Javle, Milind, Jiang, Yixing, Kang, Jung Hun, King, Gentry George, Kundranda, Madappa, Layos, Laura, Li, Daneng, Liang, Tingbo, Lonardi, Sara, Marathe, Omkar, Mondaca, Sebastian, Martin, Andrés J. Muñoz, Park, Joon Oh, Pazo Cid, Roberto, Fernandez, Paula Ribera, Rimassa, Lorenza, Alonso, Rosa Rodriguez, Sadeghi, Saeed, Scott, Aaron, Tan, Benjamin, Tougeron, David, Yan, Qiang, Yin, Xiaoyu, Zhao, Haitao

Get full text

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study by Dasari, Arvind, Lonardi, Sara, Garcia-Carbonero, Rocio, Elez, Elena, Yoshino, Takayuki, Sobrero, Alberto, Yao, James, García-Alfonso, Pilar, Kocsis, Judit, Cubillo Gracian, Antonio, Sartore-Bianchi, Andrea, Satoh, Taroh, Randrian, Violaine, Tomasek, Jiri, Chong, Geoff, Paulson, Andrew Scott, Masuishi, Toshiki, Jones, Jeremy, Csőszi, Tibor, Cremolini, Chiara, Ghiringhelli, Francois, Shergill, Ardaman, Hochster, Howard S, Krauss, John, Bassam, Ali, Ducreux, Michel, Elme, Anneli, Faugeras, Laurence, Kasper, Stefan, Van Cutsem, Eric, Arnold, Dirk, Nanda, Shivani, Yang, Zhao, Schelman, William R, Kania, Marek, Tabernero, Josep, Eng, Cathy

Get full text

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer by Gorbunova, Vera, Beck, J Thaddeus, Hofheinz, Ralf-Dieter, Garcia-Alfonso, Pilar, Nechaeva, Marina, Cubillo Gracian, Antonio, Mangel, Laszlo, Elez Fernandez, Elena, Deming, Dustin A, Ramanathan, Ramesh K, Torres, Alison H, Sullivan, Danielle, Luo, Yan, Berlin, Jordan D

Get full text

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study by Gkika, Eleni, Grosu, Anca-Ligia, Macarulla Mercade, Teresa, Cubillo Gracián, Antonio, Brunner, Thomas B, Schultheiß, Michael, Pazgan-Simon, Monika, Seufferlein, Thomas, Touchefeu, Yann

Get full text

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabi... by Wainberg, Zev A, Feeney, Kynan, Lee, Myung Ah, Muñoz, Andrés, Gracián, Antonio Cubillo, Lonardi, Sara, Ryoo, Baek-Yeol, Hung, Annie, Lin, Yong, Bendell, Johanna, Hecht, J Randolph

Get full text

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C by Almhanna, Khaldoun, Wright, David, Mercade, Teresa Macarulla, Van Laethem, Jean-Luc, Gracian, Antonio Cubillo, Guillen-Ponce, Carmen, Faris, Jason, Lopez, Carolina Muriel, Hubner, Richard A., Bendell, Johanna, Bols, Alain, Feliu, Jaime, Starling, Naureen, Enzinger, Peter, Mahalingham, Devalingham, Messersmith, Wells, Yang, Huyuan, Fasanmade, Adedigbo, Danaee, Hadi, Kalebic, Thea

Get full text

Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer by Gorbunova, Vera, Beck, J Thaddeus, Hofheinz, Ralf-Dieter, Garcia-Alfonso, Pilar, Nechaeva, Marina, Gracian, Antonio Cubillo, Mangel, Laszlo, Fernandez, Elena Elez, Deming, Dustin A, Ramanathan, Ramesh K, Torres, Alison H, Sullivan, Danielle, Luo, Yan, Berlin, Jordan D

Get full text

The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC) by Bendell, Johanna C., Sauri, Tamara, Gracián, Antonio Cubillo, Alvarez, Rafael, López‐López, Carlos, García‐Alfonso, Pilar, Hussein, Maen, Miron, Maria‐Luisa Limon, Cervantes, Andrés, Montagut, Clara, Vivas, Cristina Santos, Bessudo, Alberto, Plezia, Patricia, Moons, Veerle, Andel, Johannes, Bennouna, Jaafar, Westhuizen, Andre, Samuel, Leslie, Rossomanno, Simona, Boetsch, Christophe, Lahr, Angelika, Franjkovic, Izolda, Heil, Florian, Lechner, Katharina, Krieter, Oliver, Hurwitz, Herbert

Get full text

Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 stu... by Overman, Michael J, Gelsomino, Fabio, Aglietta, Massimo, Wong, Mark, Limon Miron, Maria Luisa, Leonard, Gregory, García-Alfonso, Pilar, Hill, Andrew G, Cubillo Gracian, Antonio, Van Cutsem, Eric, El-Rayes, Bassel, McCraith, Stephen M, He, Beilei, Lei, Ming, Lonardi, Sara

Get full text

Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guany... by Almhanna, Khaldoun, Miron, Maria Luisa Limon, Wright, David, Gracian, Antonio Cubillo, Hubner, Richard A., Van Laethem, Jean-Luc, López, Carolina Muriel, Alsina, Maria, Muñoz, Frederico Longo, Bendell, Johanna, Firdaus, Irfan, Messersmith, Wells, Ye, Zhan, Fasanmade, Adedigbo A., Danaee, Hadi, Kalebic, Thea

Get full text

Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) by Rosas, Ivan O., Bräu, Norbert, Waters, Michael, Go, Ronaldo C., Malhotra, Atul, Hunter, Bradley D., Bhagani, Sanjay, Skiest, Daniel, Savic, Sinisa, Douglas, Ivor S., Garcia-Diaz, Julia, Aziz, Mariam S., Cooper, Nichola, Youngstein, Taryn, Sorbo, Lorenzo Del, Zerda, David J. De La, Ustianowski, Andrew, Gracian, Antonio Cubillo, Blyth, Kevin G., Carratalà, Jordi, François, Bruno, Benfield, Thomas, Haslem, Derrick, Bonfanti, Paolo, van der Leest, Cor H., Rohatgi, Nidhi, Wiese, Lothar, Luyt, Charles Edouard, Bauer, Rebecca N., Cai, Fang, Lee, Ivan T., Matharu, Balpreet, Metcalf, Louis, Wildum, Steffen, Graham, Emily, Tsai, Larry, Bao, Min

Get full text

Abstract CT107: Phase II trial of TAK-264 in previously treated patients (pts) with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expression gu... by Almhanna, Khaldoun, Limon Miron, Maria Luisa, Wright, David, Cubillo Gracian, Antonio, Hubner, Richard, Van Laethem, Jean-Luc, Muriel López, Carolina, Alsina, Maria, Longo Muñoz, Federico, Bendell, Johanna, Messersmith, Wells, Yang, Huyuan, Fasanmade, Adedigbo, Danaee, Hadi, Kalebic, Thea

Get full text

Long-Term Survival in Hepatocellular Carcinoma following Second-Line Tumor Treating Fields Therapy and Sorafenib: A Case Report by Torres Velasco, Marisa, Álvarez Gallego, Rafael, Peinado, Paloma, Muñoz Gregorio, Cesar, Ugidos, Lisardo, García Morillo, Marcial, Vicente, Emilio, Quijano, Yolanda, Prados, Susana, de la Fuente, Enrique, Cubillo Gracián, Antonio

Get full text

Abstract CT117: A phase II trial of TAK-264, a novel antibody-drug conjugate (ADC), in patients with pancreatic adenocarcinoma expressing guanylyl cyclase C (GCC) by Almhanna, Khaldoun, Wright, David, Macarulla Mercadé, Teresa, Van Laethem, Jean-Luc, Cubillo Gracian, Antonio, Guillén-Ponce, Carmen, Faris, Jason, Muriel Lopez, Carolina, Hubner, Richard, Bendell, Johanna, Bols, Alain, Feliú Batlle, Jaime, Starling, Naureen, Enzinger, Peter, Mahalingham, Devalingham, Messersmith, Wells, Yang, Huyuan, Fasanmade, Adedigbo, Danaee, Hadi, Kalebic, Thea

Get full text

Erlotinib as a Single Agent in Select Subsets of Patients with Advanced Non–Small-Cell Lung Cancer by Carrión, Ramón Pérez, Gracián, Antonio Cubillo, Hernandez, Pedro Salinas

Get full text